ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Zealand Pharma clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 43 studies whose lead sponsor is Zealand Pharma. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 17, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Zealand Pharma with Takeda and Ironwood Pharmaceuticals →

Pipeline: 5 programs

Each counted once: 5 with a study Zealand Pharma leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Zealand Pharma’s own registered studies; Zealand Pharma’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

Licenses and deals

One of Zealand Pharma’s programs has a dated deal behind it: 1 developed with a partner. Each from the companies’ own releases and filings, linked; the registry does not record them.

Developed with a partner 1

What it is testing

The drugs Zealand Pharma’s studies test, most open studies first — 6 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

3 of Zealand Pharma’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. 2A
  7. M
  8. J
  9. J
  10. A
  11. 1S
  12. O
  13. N

Add all 3 to your calendar (.ics) → With an account.

All 43 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now512%
  • Under way, not recruiting12%
  • Completed3479%
  • Stopped early37%Terminated 2 · Withdrawn 1

Phase

  • Phase 116
  • Phase 315
  • Phase 210
  • Early Phase 13

Where

  • Germany25
  • United States19
  • Poland8
  • Netherlands7
  • United Kingdom7
  • Denmark7

Over the years

  1. 09
  2. 10
  3. 11
  4. 12
  5. 13
  6. 14
  7. 15
  8. 16
  9. 17
  10. 18
  11. 619
  12. 20
  13. 21
  14. 22
  15. 23
  16. 24
  17. 25
  18. 426

By the year each study started; 1 started before 2009. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Zealand Pharma.

  • Zealand Pharma
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    43 studies

Focus areas

Conditions Zealand Pharma leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 43 of 43.